ATX
Click for more information
3.28% 6.3¢ amplia therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-43

  1. Duke2
    781 Posts.
    lightbulb Created with Sketch. 197
    clock Created with Sketch.
    19/03/24
    22:49
    Post #: 72969263
    Despite having 11 sites up and running, the timeline for 26 patients enrolled and interim analysis for mid 2024 seems a stretch for me. Would love to be proven otherwise of course
    Last edited by Duke2: 19/03/24
    ATX Price at posting: 7.7¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
BIO Biome posts record sales revenue of $13M in FY24 – up 80% vs pcp and higher than forecast
right-arrow Created with Sketch.
LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
EX1 Tryptamine Therapeutics completes maiden dosing of IV psilocin – a global first
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.3¢ 		Change
0.002(3.28%) 		Mkt cap ! $17.11M
Open High Low Value Volume
6.2¢ 6.5¢ 6.1¢ $49.46K 785.1K

Buyers (Bids)

No. Vol. Price($)
1 1994 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 1562 1
View Market Depth
Last trade - 14.12pm 03/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.